Video & Transcript : 'pharmaceutical expansion' :

Page 6 of 408
KY
Transcript Highlights:
  • ...asked the pharmaceutical companies to ask the U.S.
  • </c> for the top 10 CEOs of pharmaceutical for the top 10 CEOs of pharmaceutical manufacturer manufacturer
  • All it's going to do is increase the bottom line of pharmaceutical manufacturers.
  • This is funded through pharmaceutical companies providing these discounts to us.
  • This is funded through pharmaceutical companies providing these discounts to us.
Summary: The House Standing Committee on Health Services met with a quorum and took up House Bill 785, as amended by a committee substitute that combined language from HB 785 and HB 787. The bill was described as addressing Medicaid managed care organization (MCO) audits, provider contract notice and amendment procedures, mental health parity compliance, and related transparency requirements. Supporters said the measure would tighten notice to providers, limit repeated contract amendments and rate reductions, require more standardized audit procedures, and add reporting on Medicaid claims, appeals, and grievances. It also includes a provision requiring coverage of at least two evaluation-and-management billable services per physician per recipient per date of service, and a section addressing narcotic/opioid treatment program licensing and reimbursement language. Testimony in support came from Representative Kim Moore, John Inman of BrightView Health, Michelle Sandborne of the Children’s Alliance, and Kelly Cormic of RYSE. They argued that MCOs often use audits and recoupments in ways that are burdensome, opaque, and financially damaging to providers, especially smaller and rural ones. They cited examples of multiple audit requests in short timeframes, large record requests with short deadlines, delayed or absent feedback, and recoupments taken before appeals are resolved. They also said parity laws are not being consistently enforced and that the bill would give the Department of Insurance authority to suspend or revoke an MCO certificate of authority for willful or repeated parity violations. Committee members generally expressed support for provider protections and transparency, while asking for clarification on the narcotic treatment and E/M billing provisions. Tom Stevens of the Kentucky Association of Health Plans testified in opposition, saying the bill is complex to implement and should be handled through the broader Medicaid oversight work of House Bill 9, the MOAB. He said the issues raised were better suited for that bipartisan stakeholder process and noted the committee substitute had not yet been fully reviewed by his group. After discussion, the committee adopted the committee substitute and then moved to a vote on the bill; the roll call began, with several members recorded as voting yes, but the transcript cuts off before the final vote result is shown.
OK

Oklahoma 2026 Regular Session

Appropriations REVISED Feb 18th, 2026

Appropriations

Summary: The committee met in an appropriations setting and first laid over Senate Bill 1946. It then advanced Senate Bill 1344, creating an insulin access affordability program at the Health Department, on a 19-1 vote. Senate Bill 1295, establishing a Domestic Violence Fatality Review Board revolving fund and database, was amended to delete a section and then passed 21-0. Senate Bill 1355, creating a program for memorials and headstones for eligible National Guard veterans, also passed unanimously. Members then advanced several other measures, including Senate Bill 1998 to help smaller towns qualify for quality events incentives, Senate Bill 1330 raising Pardon and Parole Board salaries, Senate Bill 1297 creating a decennial census revolving fund to support outreach for the 2030 census, and Senate Bill 1189 extending the school security fund for three more years at $50 million annually. The committee also passed Senate Bill 1338 making the Heroes Literacy Instructional Team permanent, and Senate Bill 1546 increasing scholarship support for teacher preparation students. Additional bills passed included Senate Bill 1378 creating the Olympics and Oklahoma Revolving Fund, Senate Bill 1859 creating an OSBI cyber crime and fraud unit fund, Senate Bill 1341 creating a Career Counseling Revolving Fund, Senate Bill 1377 directing DHS to provide bags for foster children’s belongings, and Senate Bill 1990 broadening the Incentive Evaluation Commission’s comparative analysis of incentives. Several bills had appropriations stripped by amendment at the chair’s request before passage, and the committee repeatedly discussed fiscal impacts, local matching expectations, transparency, and whether programs should remain state-funded or rely on local or philanthropic support. The meeting ended with adjournment and notice of a meeting the following week.
TX
Transcript Highlights:
  • We saw that quite a while back and took action where we now have the pharmaceutical companies cross-checking
  • including services such as medical nutrition therapy and medical nutrition counseling, for the potential expansion
TX
Transcript Highlights:
  • I would ask the pharmaceutical company, and I'd have them at my door the next day.
  • something... ...sinister happened during the COVID-19 pandemic, where the federal government and pharmaceutical
  • A number of physicians have petitioned the Texas Medical Board about the... expansion here, what kind
  • Senate Bill 1522 also clarifies TDI oversight by addressing expansions of existing communities, recognizing
  • clarity to other areas of the act, such as how entrance fees are escrowed when a CCRC undergoes expansion
KY
Transcript Highlights:
  • Section 5 creates the Kentucky Medicaid Pharmaceutical Rebate Fund.
  • </c><00:10:11.680><c> again</c> coverage expansions again coverage expansions again stabilize<00:10:14.120
  • rebate fund again uh in pharmaceutical rebate fund again uh in the<00:10:39.000><c> state</c><00:10:
  • We're just trying to look at new expansions.
  • Chair Petrie: Yes. and and is so expansive to our to our and and is so expansive to our to our Commonwealth
Summary: The committee first took up House Bill 537, as amended by PHS 1, which was described as a technical measure needed to ensure Kentucky can receive opioid settlement funds despite changes in bankruptcy court orders. The sponsor and Attorney General’s office explained that the bill does not change the settlement formula or substantive terms, but adjusts the mechanism for receiving the money. After brief discussion, the committee adopted PHS 1 and then passed HB 537 out favorably on a 17-0 vote, with one member recording attendance after arriving late. The committee then considered House Bill 695, also amended by PHS 1, a Medicaid stabilization bill. The sponsor said the measure is intended to hold the program steady while the legislature gathers more information and awaits work by a future Medicaid Oversight and Advisory Board. The bill would limit new waivers, state plan amendments, and coverage expansions; require reporting and record retention; create a Kentucky Medicaid Pharmaceutical Rebate Fund; direct certain behavioral health and managed care changes; and include an emergency clause. Members raised questions about the rebate fund, work requirements, and whether the bill could affect coverage or funding, while supporters emphasized transparency, data collection, and preventing new expansions until oversight is in place. Several members spoke in favor of the bill’s goals but expressed caution about micromanaging a complex program and about possible unintended consequences for beneficiaries. Representative Fleming stressed the need for stronger oversight and noted the potential fiscal impact of federal Medicaid changes. Representative Stevenson voted pass, saying the committee should let the new oversight board handle the issue, and Representative Gentry also passed, citing concern about overreach and the burden of data collection. The committee ultimately reported HB 695 favorably on a 16-1 vote with three pass votes. Afterward, members recorded additional yes votes on HB 537 for the record.
CA

California 2025-2026 Regular Session

Senate Labor, Public Employment and Retirement Committee Apr 15th, 2026

Labor, Public Employment and Retirement

Transcript Highlights:
  • This bill applies skilled and trained workforce standards to pharmaceutical facilities.
  • Pharmaceutical facilities are not typical construction projects.
  • The reliability of domestic pharmaceutical manufacturing is critical.
  • Instead, the bill represents a broad policy expansion.
  • SB 1185 is a significant expansion of state policy.
Summary: The committee heard several labor and workforce bills. SB 1059 would modernize the Employment Training Panel by allowing electronic record-keeping, digital attendance documentation, and updated training terminology; supporters said it would reduce paperwork and better match current training systems, while no opposition appeared. SB 966 would codify refinery process safety protections adopted in 2017 after the 2012 Chevron Richmond fire, including worker participation in safety proceedings, anonymous hazard reporting, access to safety information, and stop-work authority; labor supported it, while the Western States Petroleum Association opposed it as conflicting with a 2024 settlement and potentially preempted by federal labor law. SB 1024 would provide 26 weeks of paid postpartum and recovery leave for firefighters who give birth, with job restoration and no requirement to use sick or vacation time first; firefighters and labor groups strongly supported it, and the committee discussed staffing and operational coverage concerns, but no opposition testified. The committee also heard SB 1316, which would strengthen wage theft enforcement by allowing Labor Commissioner liens to be renewed, limiting employers’ late use of records, and requiring Cal/OSHA to report complaints and citations data annually. Supporters said the bill would help workers actually collect wages after long delays and prevent employers from hiding records; it passed the committee on a 5-0 vote. SB 1185 would apply skilled and trained workforce requirements to pharmaceutical facility construction and maintenance, with supporters arguing these facilities require high precision to protect public health and supply chains; construction industry opponents said the bill was an unnecessary expansion of state mandates into private projects. SB 1227 would create apprenticeship pathways into DIR enforcement jobs, including Cal/OSHA and Labor Commissioner roles, to address staffing shortages and improve labor law enforcement; supporters emphasized vacancies and backlogs, and the bill was framed as a way to build a merit-based pipeline into state service. After hearing testimony, the committee took final votes on all six bills once the full membership returned. SB 966, SB 1024, SB 1059, SB 1185, and SB 1227 were all reported out of committee, and SB 1316 was also passed and sent to the Senate Judiciary Committee. The recorded final votes were unanimous or near-unanimous in favor, with the bills advancing on 4-1 or 5-0 votes depending on the measure.
CA
Transcript Highlights:
  • This bill applies skilled and trained workforce standards to pharmaceutical facilities.
  • Pharmaceutical facilities are not typical construction projects.
  • Instead, the bill represents a broad policy expansion.
  • SB 1185 is a significant expansion of state policy. ...to California's economy.
  • SB 1185 is a significant expansion of state policy without clear evidence for its need.
Summary: The committee heard and later voted on six labor-related bills. SB 1059 would modernize the Employment Training Panel by allowing electronic record-keeping, digital attendance documentation, and updated training terminology; supporters said it would reduce paperwork and better match current workforce training practices, while no opposition appeared. SB 966 would make permanent 2017 refinery process safety protections, including worker participation in safety reviews and stop-work authority; refinery workers and unions supported it as a safeguard against rollback, while the Western States Petroleum Association opposed it, arguing it conflicted with a settlement and could be preempted by federal labor law. SB 1024 would provide 26 weeks of paid postpartum and recovery leave for firefighters who give birth and require return to the prior position; supporters said it would improve retention and equity in a male-dominated profession, and there was no opposition. The committee also heard SB 1316, which would strengthen wage theft and workplace safety enforcement by allowing renewal of labor commissioner liens, limiting employers’ late use of records, and requiring Cal/OSHA to report complaints and citations data annually. Supporters said the bill would help workers collect judgments and address long backlogs; there was no opposition, and the bill passed 4-0 on call before the full committee vote. SB 1185 would apply skilled-and-trained workforce requirements to pharmaceutical facility construction and maintenance; supporters from the building trades said these projects require specialized precision to protect public health and supply chains, while contractors opposed the bill as an unnecessary expansion of public-work-style mandates into private projects. Finally, SB 1227 would create apprenticeship pathways into Department of Industrial Relations enforcement jobs, including Cal/OSHA and the Labor Commissioner’s office, to address staffing shortages and backlogs. The author and supporters said apprenticeships could help fill vacancies while preserving the civil service merit principle and creating opportunities for displaced workers; there was no opposition. After discussion and roll calls, the committee reported all six bills out of committee, with SB 966, SB 1024, SB 1059, SB 1185, and SB 1227 sent to Appropriations, and SB 1316 sent to Judiciary.
OK

Oklahoma 2026 Regular Session

Education 2ND REVISED Apr 14th, 2026

Education

Transcript Highlights:
  • believe it's on page 23—you will see language, nope, not 23, past page 23—related to should the T-SET expansion
Committee: Senate Education
Summary: The Senate Education Committee met and first recognized visiting students and staff from Putnam City North and Edmond Public Schools. The committee then took up several House bills, beginning with HB 3312, which would require annual age-appropriate firearm safety instruction in public schools starting in the 2026–2027 school year, with CLEET and the Department of Education developing the curriculum. The bill was advanced on a 9-2 vote after the author described it as a safety measure and cited a personal tragedy involving children and a firearm. The committee also passed HB 3700, requiring colleges and universities to adopt policies ensuring grades are based only on academic performance, and HB 2981, requiring school districts to post school board meeting minutes within two weeks of approval. HB 2961, creating the Tech Sergeant Marshall Dakota Roberts Gold Star Surviving Act to provide tuition, fees, and room and board for spouses and children of Gold Star recipients at state public universities or career tech schools, passed unanimously after discussion of a possible fiscal impact. HB 3016, establishing a two-year pilot vision screening program for about 12 schools to identify convergence insufficiency disorders linked to literacy, also passed. Later, HB 4478 passed to raise the daily deposit threshold for school districts and sites from $100 to $500 while still requiring weekly deposits. HB 4326, a cleanup bill related to Oklahoma’s Promise deadlines, certified teacher definitions, and a contingent T-SET-related provision, passed after debate about its unfinished status and funding concerns. HB 3025 passed with a change excluding donations from general fund collections for carryover balance purposes for one year, and HB 3710 passed to make a new higher education program cohort-based, requiring students to begin eligibility as freshmen. The chair closed by noting the committee had moved quickly, and announced upcoming executive nominee meetings and another committee meeting the following week.
OK

Oklahoma 2026 Regular Session

Revenue and Taxation Apr 6th, 2026 at 02:00 pm

Revenue and Taxation

OK

Oklahoma 2026 Regular Session

Revenue and Taxation Apr 6th, 2026

Revenue and Taxation

Transcript Highlights:
  • So this, since it includes expansion, it might include current businesses, right?
Summary: The Senate Revenue and Taxation Committee considered several House bills dealing with tax credits, fee changes, school funding, and investment authority. House Bill 4426 extended the sunset on the SIDE tax credit to December 31, 2032, and passed 7-2. House Bill 3704 elected Oklahoma into the federal income tax credit for contributions to scholarship-granting organizations and passed 9-2. House Bill 4311 raised the unclaimed property division’s administrative fee from 4% to 6% to cover increased duties and costs; it passed 8-3 after debate over whether the increase was justified. House Bill 3044 reauthorized the veterans income tax checkoff and the associated capital improvement fund, and passed 10-0. House Bill 4191 revised the Smaller Employer Quality Jobs Act by lowering job thresholds, expanding qualifying locations and industries, and changing other eligibility rules; it passed 6-4. House Bill 3465 extended the emission tax credit sunset from July 1, 2027 to July 1, 2029 and passed 6-4, with opponents arguing it subsidized compliance with federal mandates. House Bill 3972, a title-off bill addressing ad valorem reimbursement issues tied to the state purchase of a prison, drew extensive debate over precedent and scope; an amendment to add a sunset failed 5-5, and the bill then passed 8-2 as amended.
MN

Minnesota 2025-2026 Regular Session

House Health Finance and Policy Committee 3/11/26

Health Finance and Policy

Transcript Highlights:
  • I'm struggling with this because it is a scope expansion and I feel like there isn't a guard rail here
  • I know that's not really before us today, but I just, if we're going to do this and give this expansion
  • 40:49.280><c> this</c> we're going to do this and give this we're going to do this and give this expansion
  • 50.480><c> it's</c><00:40:50.720><c> not</c><00:40:50.960><c> just</c><00:40:51.119><c> about</c> expansion
  • and say it's not just about expansion and say it's not just about athletes,<00:40:52.000><c> it's</c
AZ

Arizona 2026 Regular Session

02/18/2026 - House Transportation & Infrastructure

Transportation & Infrastructure

Transcript Highlights:
  • Unfortunately, it's a two-lane highway in need of modernization and expansion.
  • But those projects have included bridge replacements, road resurfacing, road expansions, intersection
  • geographic representation, but those projects have included bridge replacements, road resurfacing, road expansions
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Ways and Means Jun 21st, 2026 at 10:00 am

Joint Committee on Ways and Means

Transcript Highlights:
  • amount of expansion funds.
  • By foregoing further expansion, our budget, as proposed, will be able to cover the expansion achieved
  • No, there will be no expansion contracts. We will be maximizing existing...
  • There will be no expansion contracts.
  • I know we put you heavily into the pharmaceutical game now.
Keywords: 995, all
Summary: The committee heard budget testimony from Department of Mental Health Commissioner Brooke Doyle, who said DMH serves about 29,000 people and is facing rising demand, higher operating costs, and uncertainty about federal funding. She explained that the FY26 budget prioritizes fully funding the state-operated inpatient system, which is at 100% occupancy and often serves people transferred from Bridgewater State Hospital, while making reductions in other areas to balance the budget. Those reductions include a 50% cut to case managers, a pause on closing the Pocasset unit pending a working group on Cape access, and changes to youth and contracted services such as right-sizing IRTP and CIRT, reducing Youth PACT from seven teams to three, scaling back flex and jail diversion grants as ARPA funds wind down, and preserving the behavioral health helpline and community-based crisis services. Members from Western Massachusetts and the Cape raised concerns about access, staffing, and the impact of cuts, and Doyle said the department would continue operating IRTP services, improve the referral process, and work with stakeholders on the Pocasset review and other access issues. The committee also discussed school-based mental health, 988, loan forgiveness for workforce recruitment, and the role of co-response programs for law enforcement. Secretary Robin Lipson then testified for the Executive Office of Aging and Independence, describing a proposed FY26 budget increase of about 21% to support councils on aging, home care, elder abuse investigations, caregiver support, care transitions, and nutrition programs. She said the agency is managing rising demand, especially from the growing 80-plus population, and noted uncertainty around federal Older Americans Act funding after the federal disbursement agency was disbanded. To control costs, the office will manage intake and caseload growth in a fully state-funded home care program, but current clients will not lose services. Lipson also highlighted a new $1 million line item for local mini-grants to support age-friendly initiatives. In questions, members focused on elder scams, and Lipson said scams are increasing and the agency is working with banks, district attorneys, and public awareness campaigns. The Health Policy Commission’s Executive Director David Seltz presented the agency’s FY26 request and said the biggest challenge is health care affordability, with family premiums near $29,000 annually and many residents delaying care because of cost. He emphasized that recent legislation significantly expands HPC’s role through a new Office of Pharmaceutical Policy and Analysis, which will examine the drug supply chain and pricing, and a new Office of Health Resource Planning, which will support statewide planning around closures and access gaps. The new law also creates task forces on maternal health access and primary care, and adds transparency and oversight for private equity in health care. Members asked about pharmaceutical costs, GLP-1 weight-loss drugs, 340B, and maternal health closures; Seltz said the data show rapid growth in GLP-1 spending and that the new offices will help the state better understand cost drivers and access problems. The Center for Health Information and Analysis then began its testimony, describing its role as the state’s data hub for health care spending, utilization, quality, and affordability analysis.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Financial Services Jun 21st, 2026 at 10:30 am

Joint Committee on Financial Services

Transcript Highlights:
  • I'm Senior Director of State Affairs at Pharmaceutical Care Management Association, otherwise known as
  • Pharmaceutical manufacturers are refusing to ship 340B-priced drugs to CHC, or community health center
  • It also requires pharmaceutical manufacturers to ship 340B-priced drugs to pharmacy health centers and
  • HDA is the national trade association representing pharmaceutical wholesale distributors.
  • HDA is the national trade association representing pharmaceutical wholesale distributors.
Keywords: 995, all
Summary: The committee held a lengthy hearing on a large docket of pharmacy and drug-pricing bills, with most testimony focused on PBM reform, 340B drug discount program protections, specialty medication access, and medication adherence. Chair James Murphy and Senator Paul Feeney opened the hearing and took testimony from legislators, patient advocates, pharmacists, health center leaders, industry representatives, and policy groups. Several speakers described delays, denials, high out-of-pocket costs, and pharmacy closures tied to PBM practices, while others emphasized the importance of community health centers and independent pharmacies in serving patients. On the 340B program, supporters including Senator Eldridge, Senator Payano, Community Care Cooperative, Fenway Health, the Massachusetts League of Community Health Centers, and several community health center leaders argued that bills such as H. 1107 and S. 819 would stop discriminatory PBM and manufacturer practices, preserve contract pharmacy access, and protect safety-net providers that say they reinvest savings into care, pharmacy expansion, interpreter services, behavioral health, and other services. Opponents including PhRMA, the Community Liver Alliance, and a public policy analyst argued the program lacks transparency and accountability, has grown beyond its original purpose, and may benefit large hospitals and for-profit entities more than low-income patients. They urged more reporting and oversight rather than expanding protections. On PBM reform, testimony supported bills including H. 1157, H. 1234, S. 724, S. 831, and related measures that would require rebate pass-through, ban spread pricing, limit steering to PBM-owned pharmacies, and improve reimbursement for community pharmacies. Independent pharmacists and patients said current PBM practices raise costs, create administrative burdens, and threaten access to local pharmacies. PCMA, representing PBMs, opposed the reforms, arguing PBMs lower costs, that plan sponsors choose to contract with them, and that the Health Policy Commission and CHIA should complete their ongoing study before new mandates are adopted. The committee also heard support for H. 1322 and S. 734 on specialty medications, and for H. 781 and H. 1305 on medication synchronization to improve adherence. No votes or formal actions were taken during the hearing.
HI

Hawaii 2025 Regular Session

HHS-CPN, CPN, CPN DEFER Public Hearings 03-19-2025

Health and Human Services

Transcript Highlights:
  • > impact of the pharmaceutical impact of the pharmaceutical restrictions<00:25:35.919><c> is</c><00:25
  • </c><00:29:24.720><c> companies</c> made by the pharmaceutical companies made by the pharmaceutical companies
  • Goo or I don't pharmaceutical guys, Mr.
  • </c> concerns that the pharmaceutical concerns that the pharmaceutical companies<00:30:59.360><c> have
  • c><00:31:47.200><c> focused</c><00:31:47.600><c> mostly</c> an expansion that has focused mostly an expansion
Keywords: 912, senate, all
Summary: The committee heard testimony on HB 302, which would expand access to medical cannabis by removing the in-person provider-patient relationship requirement and related restrictions. The Department of Health supported the bill, and multiple advocates and organizations testified in support, including the ACLU of Hawaii, Hawaii Alliance for Cannabis Reform, Marijuana Policy Project, and others. Supporters said the measure would improve access for patients, especially on outer islands, and some urged broader amendments allowing providers to certify cannabis for any medical condition and to speed registration and treat in-state and out-of-state patients equally. No opposition was heard, and the bill was left with no questions after testimony. The committee also heard HB 1052 HD1, which clarifies that the Public Utilities Commission may use universal service fund monies to provide free telecommunications access for individuals with print disabilities. Testimony was uniformly supportive from the DCCA Division of Consumer Advocacy, the State Council on Developmental Disabilities, the Department of Human Services, the Public Utilities Commission, and the National Federation of the Blind of Hawaii. Witnesses described the program as an important accessibility service that has been operating under prior appropriations and should continue under the universal service program. HB 1482, relating to controlled substances and hemp/synthetic cannabinoids, drew support from the Department of Law Enforcement, Department of Health, Honolulu Police Department, and others, with some comments from the Attorney General’s office. Supporters said the bill would clarify that delta-8 THC is a controlled substance and help enforcement against illegal hemp products and synthetic cannabinoids. Testimony and questioning focused on the need for better lab testing capacity, retail registry and age-gating, seizure authority, nuisance abatement, and possible use of special funds or appropriations to support enforcement. Members also discussed enforcement of illegal hemp businesses and whether additional funding or statutory changes would be needed. Finally, the committee took up HB 712, a 340B drug-discount measure affecting safety-net providers and contract pharmacies. Hospitals, health centers, and provider groups testified in support, saying the bill would protect access to discounted drugs and preserve funding for services such as chronic disease management, transportation, and specialty care. Pharmaceutical-industry representatives opposed the bill or sought amendments, arguing the 340B program has expanded beyond its original intent and lacks transparency, and they requested reporting or audit-like provisions to verify claims and revenues. Members questioned both sides about alleged abuse, the growth of contract pharmacies, and whether the bill should include transparency requirements before moving forward.
KY
Transcript Highlights:
  • This expansion was done with the agreement of the pharmaceutical industry in order to have a place at
  • ><c> the</c><00:08:39.640><c> pharmaceutical</c><00:08:40.680><c> industry</c> agreement of the pharmaceutical
  • </c><00:26:28.279><c> iCal</c> entirely supported by pharmaceutic iCal entirely supported by pharmaceutic
  • </c> not one single pharmaceutical not one single pharmaceutical manufacturer<00:27:01.640><c> in</c>
  • The pharmaceutical company agreed to that. For whatever reason, they were squeezed.
Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.
MN

Minnesota 2025-2026 Regular Session

Committee on Judiciary and Public Safety - Part 2 - 03/27/26

Judiciary and Public Safety

Transcript Highlights:
  • 24:02.160><c> is</c> Of those trillions, pharmaceutical is Of those trillions, pharmaceutical is the<
  • <01:24:13.080><c> companies</c> pharmaceutical companies pharmaceutical companies spend<01:24:15.600>
  • </c> millions of dollars on pharmaceuticals. millions of dollars on pharmaceuticals.
  • </c> many pharmaceutical commercials either. many pharmaceutical commercials either.
  • </c> profit margin of the pharmaceutical profit margin of the pharmaceutical company?
Keywords: 1187, senate, all